WallStreetZenWallStreetZen

NASDAQ: VYGR
Voyager Therapeutics Inc Stock Ownership - Who owns Voyager Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Voyager Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alfred SandrockPresident and CEO2026-04-0211,511$3.87
$44.55kSell
Alfred SandrockPresident and CEO2026-02-2414,197$3.79
$53.81kSell
Todd Alfred CarterChief Scientific Officer2026-02-244,174$3.76
$15.69kSell
Robin SwartzCOO CBO2026-02-246,458$3.77
$24.35kSell
Nathan D. JorgensenChief Financial Officer2026-02-244,668$3.77
$17.60kSell
Alfred SandrockPresident and CEO2026-02-1811,732$3.41
$40.01kSell
Todd Alfred CarterChief Scientific Officer2026-02-183,301$3.44
$11.36kSell
Robin SwartzCOO CBO2026-02-183,882$3.44
$13.35kSell
Alfred SandrockPresident and CEO2026-02-1012,192$3.78
$46.09kSell
Robin SwartzCOO CBO2026-02-104,569$3.85
$17.59kSell

1 of 2

VYGR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYGR insiders and whales buy or sell their stock.

VYGR Shareholders

What type of owners hold Voyager Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Neurocrine Biosciences Inc13.92%8,575,316$28.30MInsider
Ecor1 Capital LLC13.19%8,128,014$26.82MInsider
Mark J. Levin10.43%6,427,874$21.21MInsider
Sanofi4.02%2,477,941$8.18MInsider
Steven M. Paul1.42%872,351$2.88MInsider
Alfred Sandrock0.77%472,549$1.56MInsider
Hadley Harbor Master Investors Cayman LP0.76%470,588$1.55MInsider
Andre Turenne0.52%322,375$1.06MInsider
Robin Swartz0.32%199,738$659.14kInsider
Toby Ferguson0.30%183,914$606.92kInsider

1 of 3

VYGR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYGR0.06%48.15%Net Selling
MSLE0.04%0.00%
PEPG0.08%9.73%Net BuyingNet Selling
CHRS0.05%14.00%Net Selling
ORMP0.04%53.95%Net SellingNet Selling
View Top Biotech Stocks

Voyager Therapeutics Stock Ownership FAQ

Who owns Voyager Therapeutics?

Voyager Therapeutics (NASDAQ: VYGR) is owned by 0.06% institutional shareholders, 48.15% Voyager Therapeutics insiders, and 51.79% retail investors. Neurocrine Biosciences Inc is the largest individual Voyager Therapeutics shareholder, owning 8.58M shares representing 13.92% of the company. Neurocrine Biosciences Inc's Voyager Therapeutics shares are currently valued at $28.30M.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.